✦ LIBER ✦

Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients

✍ Scribed by B. Vandercam; J. Gérain; Y. Humblet; A. Ferrant; G. Wauters; M. Moreau; J. Longueville; M. Symann; N. Straetmans

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ceftazidime sodium carbonate versus ceft

✍ C. Verhagen; B. E. De Pauw; K. J. Williams; W. Du Bois 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 538 KB

Meropenem monotherapy versus combination

✍ G. Behre; H. Link; G. Maschmeyer; P. Meyer; U. Paaz; M. Wilhelm; W. Hiddemann 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 189 KB

Empirical monotherapy with meropenem ver

✍ P. M. Shah; W. Stille; A. Böhme; R. Schaumann; A. Heller; S. Halir; H. -G. Fuhr; 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 688 KB

Clinafloxacin monotherapy (CI-960) versu

✍ M. P. Glauser; U. Brennscheidt; O. Cornely; A. Grigg; A. Figuera; C. Keyserling; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Monotherapy with piperacillin/tazobactam

✍ U. Hess; C. Böhme; K. Rey; H. J. Senn 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 86 KB

Ceftazidime and amikacin as empiric trea

✍ C.R. Santhosh-Kumar; D.S.S. Ajarim; M.S. Harakati; A.K. Al Momen; F. Al Mohareb; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 532 KB